Novo Nordisk doubles stock of Wegovy starter doses but supply constraints persist
Gilead’s Kite gets FDA approval for faster CAR-T therapy manufacturings
GSK sees strong growth as Haleon split and vaccine drive pays off
Biogen abandons Aduhelm efforts
